Sintilimab-Induced Sequential Multi-System Severe Immune-Related Adverse Events in an Elderly Patient with Esophageal Squamous Cell Carcinoma: A Case Report and Literature Review
{{output}}
Immune checkpoint inhibitors (ICIs) can induce a spectrum of immune-related adverse events (irAEs), yet sequential, multi-organ severe irAEs remain uncommon and challenging to manage. We present a 78-year-old male patient with esophageal squamous cell carcinom... ...
